{
    "clinical_study": {
        "@rank": "95619", 
        "arm_group": [
            {
                "arm_group_label": "Arm 1(with twice-daily TRT)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Arm 2 (with once-daily TRT)", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_title": "Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Limited Disease Small Cell Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Lung Neoplasms", 
                "Small Cell Lung Carcinoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically or cytologically (if cannot be proven histologically, at least twice\n             positive findings on fine needle aspiration or sputum cytology) confirmed SCLC\n\n          -  Limited stage (Clinical stage I-IIIb, lesion limited to one side of thorax, e.g.\n             Excluding T4 disease with malignant pleural effusion or N3 disease with contralateral\n             hilum/supraclavicular lymph node invasion).\n\n          -  Measurable or assessable lesion\n\n          -  Age over 18 years old\n\n          -  Performance status (ECOG scale): 0~2\n\n          -  Adequate organ functions: ANC \u2265 1500/ul, PLT \u2265 100 x 103/u, Total Bilirubin \u2264 1.5\n             mg/dl, Creatinine \u2264 1.5 mg/dl\n\n          -  Inclusion of tumor within the limited radiation field without significant loss of\n             pulmonary function (confirmed by radiation oncologist)\n\n          -  Sexually active fertile men and women using a contraceptive method\n\n          -  Patients should sign a written informed consest before study entry\n\n        Exclusion Criteria:\n\n          -  T4 disease with malignant pleural effusion; N3 disease with contralateral\n             hilum/supraclavicular lymph node invasion\n\n          -  Lesion with mixed small cell nonsmall cell feature (pathologically)\n\n          -  prior chemotherapy or radiation therapy.\n\n          -  Pericardial or pleural effusion on chest X-ray image regardless of cytological\n             finding\n\n          -  T4 disease with tumor invasion to great vessels, heart, trachea, or esophagus;\n             Concerns about possible perforation by tumor necrosis\n\n          -  Severe comorbidities such as cardiac disease with symptom, myocardiac infarction\n             within 6 months, chronic obstructive pulmonary disease with FEV1 less than 1.0\u2113, or\n             uncontrolled bronchospasm of unaffected lung\n\n          -  With atelectasis that makes GTV unidentifiable\n\n          -  Other primary malignancy (except in situ carcinoma of the cervix or adequately\n             treated basal cell carcinoma of the skin or prior malignancy treated more than 3\n             years ago without recurrence)\n\n          -  Uncontrolled psychiatric disorder, serious head injury, chronic alcoholism, drug\n             addiction and central nervous system disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01710956", 
            "org_study_id": "NCCCTS-11-531"
        }, 
        "intervention": {
            "arm_group_label": [
                "Arm 1(with twice-daily TRT)", 
                "Arm 2 (with once-daily TRT)"
            ], 
            "description": "Arm 1: with twice-daily thoracic radiotherapy daily 1.5gy/fr. bid, total 45gy(30fr during 3weeks) Arm 2: with once-daily thoracic radiotherapy daily 2.4gy/fr. qd, total 60gy(25fr during 5weeks)", 
            "intervention_name": "Arm 1: with twice-daily thoracic radiotherapy/ Arm 2: with once-daily thoracic radiotherapy", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "concurrent chemoradiation in patients with limited disease small cell lung cancer", 
        "lastchanged_date": "October 17, 2012", 
        "location": [
            {
                "contact": {
                    "email": "ncckrog@ncc.re.kr", 
                    "last_name": "Kwan Ho Cho, M.D.", 
                    "phone": "+82 31 920 1720"
                }, 
                "contact_backup": {
                    "email": "ncckrog@ncc.re.kr", 
                    "last_name": "Sung Ho Moon, M.D.", 
                    "phone": "+82 31 920 1726"
                }, 
                "facility": {
                    "address": {
                        "city": "Ilsan-ro 323, Ilsandoung-gu, Goyang-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "410-769"
                    }, 
                    "name": "National Cancer Canter, Korea"
                }, 
                "investigator": [
                    {
                        "last_name": "Sung Ho Moon, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jin Soo Lee, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Heung Tae Kim, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ji Youn Han, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Tak Yun, M.D", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Young Joo Lee, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Geon Kook Lee, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Hyae Young Kim, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Byung Ho Nam, Statistician", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kwancho@ncc.re.kr", 
                    "last_name": "Kwan Ho Cho, M.D.", 
                    "phone": "+82 31 920 1720"
                }, 
                "contact_backup": {
                    "email": "shmoon@ncc.re.kr", 
                    "last_name": "Sung Ho Moon, M.D.", 
                    "phone": "+82 31 920 1726"
                }, 
                "facility": {
                    "address": {
                        "city": "Ilsan-ro 323, Ilsandoung-gu, Goyang-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "410-769"
                    }, 
                    "name": "National Cancer Canter, Korea"
                }, 
                "investigator": [
                    {
                        "last_name": "Sung Ho Moon, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jin Soo Lee, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Heung Tae Kim, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ji Youn Han, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Tak Yun, M.D", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Young Joo Lee, M.D.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Phase II Study of Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer", 
        "overall_contact": {
            "email": "kwancho@ncc.re.kr", 
            "last_name": "Kwan Ho Cho, M.D.", 
            "phone": "+82 31 920 1720"
        }, 
        "overall_contact_backup": {
            "email": "shmoon@ncc.re.kr", 
            "last_name": "Sung Ho Moon, M.D.", 
            "phone": "+82 31 920 1726"
        }, 
        "overall_official": {
            "affiliation": "National Cancer Center, Korea", 
            "last_name": "Kwan Ho Cho, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "progression free survival", 
            "safety_issue": "No", 
            "time_frame": "5years after chemoradiotherapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01710956"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Cancer Center, Korea", 
            "investigator_full_name": "Kwan Ho Cho", 
            "investigator_title": "PI", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National Cancer Center, Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Center, Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}